StockData
EoCene Ltd. logo

EoCene Ltd. (EOCN) stock

EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 31, 2026Score 5/30
$2.46−0.07 (-2.77%)

Close on Nov 17, 2026Market cap $2.46MP/E –Yield –

EoCene price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

EoCene's price to sales ratio was 50.3× on Feb 28, 2020, against 159.6× a year earlier. Over the last 3 years it ranged from 43.4× to 261.8×, with a median of 134.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Feb 28, 202050.3×−9.6
2019Dec 31, 201959.9×−71.7
2018Dec 31, 2018131.7×−107.8
2017Dec 29, 2017239.4×–

More EoCene figures

See a number that looks wrong?